No Prescription |
 |
 | ||
|
Cromolux Eye Drop 2% Opticrom |
|
| ||
No Prescription » Prescription Drugs 5 » Cromolux Eye Drop 2% Opticrom This medicine contains the active ingredient sodium cromoglicate (previously spelt cromoglycate in the UK) which is a type of medicine used to relieve the symptoms of allergies. Sodium cromoglicate eye drops are used to relieve the symptoms of eye allergies such as hayfever.Sodium cromoglicate works by reducing allergic responses. It is not fully understood how it does this but it is thought to work by 'stabilising' immune cells called mast cells. Mast cells are an important part of the immune system. They become sensitised when they are exposed to foreign particles or allergens for example pollen or dust mites. When this happens the mast cells release substances that include histamine and these subsequently go on to cause inflammation as part of the bodyÆs immune response to fight the foreign substance. Inflammation of the eye causes the typical symptoms of an eye allergy - redness itching and a watery discharge.By stabilising the mast cells sodium cromoglicate is thought to prevent the substances that cause the inflammation eg histamine from being released when the cells encounter an allergen. This prevents the allergic response and relieves the symptoms of the allergy.Sodium cromoglicate eye drops are used to reduce the symptoms of eye allergies (allergic conjunctivitis) such as hayfever. They provide relief from red itchy watery and puffy eyes and work best when they are used regularly to prevent the allergy even when you don't have symptoms.What is it used for?Allergic conjunctivitis Buy Cromolux Eye Drop 2% Opticrom and other Prescription Drugs 5 products online at Medstore. 208
About Cromolux Eye Drop 2% Opticrom: Product Type: Prescription Drugs 5 Cromolux Eye Drop 2% ( Opticrom Crolom Generic Sodium Cromoglycate ) Cromolux Eye Drop 2% (Opticrom Crolom Generic Sodium Cromoglycate) Opticrom Crolom Generic Sodium Cromoglycate 2% 10ml (1 bottle) Opticrom Crolom Generic Sodium Cromoglycate Cromolux Eye Drop 2%
View more Prescription Drugs 5 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
